Mixed Reality Display Improves Cardiac Ablation Accuracy

The results showed there was no difference in navigation times with either ELVIS or EAMS, but the physicians were significantly more accurate with ELVIS, with an error margin of just 2.99 mm, compared to 4.50 mm for EAMS. When translated to cardiac ablation outcomes, 34% of the ablation lesions created using EAMS would be made outside of the target area, as opposed to just 6% when using the ELVIS 3D display. The study was published…

"Mixed Reality Display Improves Cardiac Ablation Accuracy"

Harvis: an interactive virtual reality tool for hemodynamic modification and simulation

In this article, authors present new vascular simulations with VR visualisation. We thus developed Harvis, a software platform with a flexible GUI for performing vascular simulations and a VR-capable interface for geometry modification and flow visualization. The aim of Harvis is to streamline and integrate this process for research use and future clinical applications. Source: Harvis: an interactive virtual reality tool for hemodynamic modification and simulation – ScienceDirect

"Harvis: an interactive virtual reality tool for hemodynamic modification and simulation"

VR helps cardiologist detect patient’s injury and repair a broken heart

onning the VR headset, Steinberg was able to enlarge the heart to see the degree of blockage and its location in the vessel. He could see the hole in the septum and its proximity to vessels and, importantly, to the mechanical aortic valve implanted in Cronk in 2011. “When you’re implanting devices with a catheter, you don’t want to fix one problem only to create another,” Steinberg said. “The VR perspective gave us landmarks and…

"VR helps cardiologist detect patient’s injury and repair a broken heart"

The Living Heart: FDA renews contract with Dassault to evaluate 3D simulation, virtual patients

The Living Heart Project of Dassault Systèmes allows virtual experiments on medical devices and even drugs since last year. There are now 130 partners in this project and the collaboration with the FDA could increase this number. The next step for Dassault Systèmes is to plan medical trials with virtual patients. With the demonstration of efficiency of this process, future medical trails could be very different from today and much more accurate. Dassault Systèmes today…

"The Living Heart: FDA renews contract with Dassault to evaluate 3D simulation, virtual patients"